Expression profiling of skeletal muscle in young bulls treated with steroidal growth promoters

Physiological Genomics

Volumn 38, Issue 2, 2009, Pages 138-148

  Carraro, L ^a   Ferraresso, S ^a   Cardazzo, B ^a   Romualdi, C ^a   Montesissa, C ^a   Gottardo, F ^a   Patarnello, T ^a   Castagnaro, M ^a   Bargelloni, L ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Dexamethasone; Estradiol; Microarray; Myostatin

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; DEXAMETHASONE; ESTRADIOL; GROWTH PROMOTOR; MYOSTATIN; OLIGONUCLEOTIDE; WNT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BEEF CATTLE; BULL (BOVINE); BULL (MAMMAL); CELL MOTILITY; CELL SHAPE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DNA MICROARRAY; DOWN REGULATION; GENE; GENE EXPRESSION; GENE NUMBER; MALE; MICROARRAY ANALYSIS; MUSCLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; UPREGULATION;

ANIMALS; CATTLE; DEXAMETHASONE; DNA PRIMERS; ESTRADIOL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; MALE; MUSCLE, SKELETAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; BOS;

EID: 67650269852     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00014.2009     Document Type: Article

References (84)

1. Adams NR, Sanders MR. Improved feed intake and body weight change in sheep treated with dexamethasone at entry into pens or feedlots. Austr Vet J 69: 209-213, 1992.
2. Balizs G, Hewitt A. Determination of veterinary drug residues by liquid chromatography and tandem mass spectrometry. Anal Chim Acta 492: 105-131, 2003.
3. Becknell B, Shen T, Maghraby E, Taya S, Kaibuchi K, Caligiuri MA, Marcucci G. Characterization of leukemia-associated Rho guanine nucleotide exchange factor (LARG) expression during murine development. Cell Tissue Res 314: 361-366, 2003.
4. Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, Rando TA. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317: 807-810, 2007
5. Brscic M, Miotello S, Mazzenga A, Cozzi G, Gottardo F. Growth performance and behaviour of finishing beef cattle illegally treated with growth promoters. Ital J Anim Sci 6: 403-405, 2007.
6. Bryan BA, Li D, Wu X, Liu M. The Rho family of small GTPases: crucial regulators of skeletal myogenesis. Cell Mol Life Sci 62: 1547-1555, 2005.
7. Bryan BA, Mitchell DC, Zhao L, Ma W, Stafford LJ, Teng BB, Liu M. Modulation of muscle regeneration, myogenesis, and adipogenesis by the Rho family guanine nucleotide exchange factor GEFT. Mol Cell Biol 25: 11089-11101, 2005.
8. 1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice. Am J Pathol 166: 253-263, 2005.
9. Cassar-Malek I, Passelaigue F, Bernard C, Léger J, Hocquette JF. Target genes of myostatin loss-of-function in muscles of late bovine fetuses. BMC Genomics 8: 63, 2007.
10. Cossu G, Borello U. Wnt signaling and the activation of myogenesis in mammals. EMBO J 18: 6867-6872, 1999.
11. Council Directive 86/609/EEC. Off J Eur Commun L358, 1986.
12. Council Directive 96/22/EC. Off J Eur Commun L125: 3, 1996.
13. Council Directive 96/23/EC. Off J Eur Commun L125: 10, 1996.
14. Courtheyn D, Le Bizec B, Brambilla G, De Brabander HF, Cobbaert E, Van de Wiele M, Vercammen J, De Wasch K. Recent developments in the use and abuse of growth promoters. Anal Chim Acta 473: 71-82, 2002.
15. Dallman M, Strack A, Akana S, Bradbury M, Hanson E, Scribner K, Smith M. Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol 14: 303-347, 1993.
16. DasGupta R, Kaykas A, Moon RT, Perrimon N. Functional genomic analysis of the Wnt-wingless signaling pathway. Science 308: 826-833, 2005.
17. Dubowitz V, Kinali M, Main M, Mercuri E, Muntoni F. Remission of clinical signs in early Duchenne muscular dystrophy on intermittent low-dosage prednisolone therapy. Eur J Paediatr Neurol 6: 153-159, 2002.
18. Frauman A. An overview of the adverse reaction to adrenal corticosteroids. Adverse Drug React Toxicol Rev 15: 203-206, 1996.
19. Gilson H, Schakman O, Combaret L, Lause P, Grobet L, Attaix D, Ketelslegers JM, Thissen JP. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. Endocrinology 148: 452-460, 2007.
20. Giorgino F, Smith RJ. Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways. J Clin Invest 96: 1473-1483, 1995.
21. Girgenrath M, Weng S, Kostek CA, Browning B, Wang M, Brown SA, Winkles JA, Michaelson JS, Allaire N, Schneider P, Scott ML, Hsu YM, Yagita H, Flavell RA, Miller JB, Burkly LC, Zheng TS. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J 25: 5826-5839, 2006.
22. Goto A, Matsushita K, Gesellchen V, El Chamy L, Kuttenkeuler D, Takeuchi O, Hoffmann JA, Akira S, Boutros M, Reichhart JM. Akirins are highly conserved nuclear proteins required for NF-kappaB-dependent gene expression in drosophila and mice. Nat Immunol 9: 97-104, 2008.
23. Gottardo F, Brscic M, Pozza G, Ossensi C, Contiero B, Marin A, Cozzi G. Administration of dexamethasone per os in finishing bulls. I. Effects on productive traits, meat quality and cattle behavior as indicator of welfare. Animal 2: 1073-1079, 2008.
24. Gros J, Serralbo O, Marcelle C. WNT11 acts as a directional cue to organize the elongation of early muscle fibres. Nature 457: 589-593, 2009.
25. Guerriero V Jr, Florini JR. Dexamethasone effects on myoblast proliferation and differentiation. Endocrinology 106: 1198-1202, 1980.
26. Horsley V, Jansen KM, Mills ST, Pavlath GK. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113: 483-494, 2003.
27. Idol RA, Robledo S, Du HY, Crimmins DL, Wilson DB, Ladenson JH, Bessler M, Mason PJ. Cells depleted for RPS19, a protein associated with Diamond Blackfan Anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production. Blood Cells Mol Dis 39: 35-43, 2007.
28. Istasse L, De Haan V, Van Eenaeme C, Buts B, Baldwin P, Gielen M, Demeyer D, Bienfait JM. Effects of dexamethasone injections on performances in a pair of monozygotic cattle twins. J Anim Physiol Anim Nutr 62: 150-158, 1989.
29. Jahng JW, Kim NY, Ryu V, Yoo SB, Kim BT, Kang DW, Lee JH. Dexamethasone reduces food intake, weight gain and the hypothalamic 5-HT concentration and increases plasma leptin in rats. Eur J Pharmacol 581: 64-70, 2008.
30. Karasawa T, Yokokura H, Kitajewski J, Lombroso PJ. Frizzled-9 is activated by Wnt-2 and functions in Wnt/beta -catenin signaling. J Biol Chem 277: 37479-37486, 2002.
31. Kim KA, Wagle M, Tran K, Zhan X, Dixon MA, Liu S, Gros D, Korver W, Yonkovich S, Tomasevic N, Binnerts M, Abo A. R-Spondin family members regulate the Wnt pathway by a common mechanism. Mol Biol Cell 19: 2588-2596, 2008.
32. Kinyamu HK, Archer TK. Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression. Mol Cell Biol 23: 5867-5881, 2003.
33. Lethimonier C, Flouriot G, Valotaire Y, Kah O, Ducouret B. Transcriptional interference between glucocorticoid receptor and estradiol receptor mediates the inhibitory effect of cortisol on fish vitellogenesis. Biol Reprod 62: 1763-1771, 2000.
34. Lethimonier C, Flouriot G, Kah O, Ducouret B. The glucocorticoid receptor represses the positive autoregulation of the trout estrogen receptor gene by preventing the enhancer effect of a C/EBPbeta-like protein. Endocrinology 143: 2961-2974, 2002.
35. Li Y, Negishi S, Sakamoto M, Usas A, Huard J. The use of relaxin improves healing in injured muscle. Ann NY Acad Sci 1041: 395-397, 2005.
36. Li J, Wang CY. TBL1-TBLR1 and beta-catenin recruit each other to Wnt target-gene promoter for transcription activation and oncogenesis. Nat Cell Biol 10: 160-169, 2008.
37. 1-integrin promotes muscle cell proliferation, adhesion, and resistance to apoptosis without changing gene expression. Am J Physiol Cell Physiol 294: C627-C640, 2008.
38. Ma K, Mallidis C, Artaza J, Taylor W, Gonzalez-Cadavid N, Bhasin S. Characterization of 5′-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am J Physiol Endocrinol Metab 281: E1128-E1136, 2001.
39. Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N, Arias J, Salehian B. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 285: E363-E371, 2003.
40. Marin A, Pozza G, Gottardo F, Moro L, Stefani AL, Cozzi G, Brscic M, Andrighetto I, Ravarotto L. Administration of dexamethasone per os in finishing bulls. II. Effects on blood parameters used as indicators of animal welfare. Animal 2:7: 1080-1086, 2008.
41. Marshall A, Salerno MS, Thomas M, Davies T, Berry C, Dyer K, Bracegirdle J, Watson T, Dziadek M, Kambadur R, Bower R, Sharma M. Mighty is a novel promyogenic factor in skeletal myogenesis. Exp Cell Res 314: 1013-1029, 2008.
42. McCormick KM, Burns KL, Piccone CM, Gosselin LE, Brazeau GA. Effects of ovariectomy and estrogen on skeletal muscle function in growing rats. J Muscle Res Cell Motil 25: 21-27, 2004.
43. Miura P, Andrews M, Holcik M, Jasmin BJ. IRES-mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cells. PLoS ONE 3: e2309, 2008.
44. Mounier C, Posner BI, Can J. Transcriptional regulation by insulin: from the receptor to the gene. Physiol Pharmacol 84: 713-724, 2006.
45. Muslin AJ. Role of raf proteins in cardiac hypertrophy and cardiomyocyte survival. Trends Cardiovasc Med 15: 225-229, 2005.
46. Nielsen S, Pedersen BK. Skeletal muscle as an immunogenic organ. Curr Opin Pharmacol 8: 346-351, 2008.
47. Nowak SJ, Gonzalez K, Baylies MK. Bhringi, a highly conserved regulator of Twist transcription factor activity. Dros Res Conf 48: 337, 2007.
48. Otto A, Schmidt C, Luke G, Allen S, Valasek P, Muntoni F, Lawrence-Watt D, Patel K. Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration. J Cell Sci 121: 2939-2950, 2008.
49. Patel K, Amthor H. The function of myostatin and strategies of myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle. Neuromuscul Disord 15: 117-126, 2005.
50. Pelosi M, Marampon F, Zani BM, Prudente S, Perlas E, Caputo V, Cianetti L, Berno V, Narumiya S, Kang SW, Musarò A, Rosenthal N. ROCK2 and its alternatively spliced isoform ROCK2m positively control the maturation of the myogenic program. Mol Cell Biol 27: 6163-6176, 2007.
51. Perez-Ruiz A, Ono Y, Gnocchi VF, Zammit PS. beta-Catenin promotes self-renewal of skeletal-muscle satellite cells. J Cell Sci 121: 1373-1382, 2008.
52. Perrett T, Wildman BK, Jim GK, Vogstad AR, Fenton RK, Hannon SJ, Schunicht OC, Abutarbush SM, Booker CW. Evaluation of the efficacy and cost-effectiveness of melengestrol acetate in feedlot heifer calves in western Canada. Vet Ther 9: 223-240, 2008.
53. Polesskaya A, Seale P, Rudnicki MA. Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration. Cell 113: 841-852, 2003.
54. Pritchard CA, Hayes L, Wojnowski L, Zimmer A, Marais RM, Norman JC. B-Raf acts via the ROCKII/LIMK/cofilin pathway to maintain actin stress fibers in fibroblasts. Mol Cell Biol 24: 5937-5952, 2004.
55. Rafacho A, Cestari TM, Taboga SR, Boschero AC, Bosqueiro JR. High doses of dexamethasone induce increased β-cell proliferation in pancreatic rat islets. Am J Physiol Endocrinol Metab 296: E681-E689, 2009.
56. Ratcliffe MJ, Itoh K, Sokol SY. A positive role for the PP2A catalytic subunit in Wnt signal transduction. J Biol Chem 275: 35680-35683, 2000.
57. Reiter M, Walf VM, Christians A, Pfaffl MW, Meyer HH. Modification of mRNA expression after treatment with anabolic agents and the usefulness for gene expression-biomarkers. Anal Chim Acta 586: 73-81, 2007.
58. Rhen T, Cidlowski JA. Estrogens and glucocorticoids have opposing effects on the amount and latent activity of complement proteins in the rat uterus. Biol Reprod 74: 265-274, 2006.
59. Richardson BE, Beckett K, Nowak SJ, Baylies MK. SCAR/WAVE and Arp2/3 are crucial for cytoskeletal remodeling at the site of myoblast fusion. Development 134: 4357-4367, 2007.
60. Rodgers BD, Weber GM, Kelley KM, Levine MA. Prolonged fasting and cortisol reduce myostatin mRNA levels in tilapia larvae; short-term fasting elevates. Am J Physiol Regul Integr Comp Physiol 284: R1277-R1286, 2003.
61. Rodgers BD, Garikipati DK. Clinical, agricultural, and evolutionary biology of myostatin: a comparative review. Endocr Rev 29: 513-534, 2008.
62. Sadkowski T, Jank M, Zwierzchowski L, Siadkowska E, Oprzadek J, Motyl T. Gene expression profiling in skeletal muscle of Holstein-Friesian bulls with single-nucleotide polymorphism in the myostatin gene 5′-flanking region. J Appl Genet 49: 237-250, 2008.
63. Sakuma K, Nishikawa J, Nakao R, Watanabe K, Totsuka T, Nakano H, Sano M, Yasuhara M. Calcineurin is a potent regulator for skeletal muscle regeneration by association with NFATc1 and GATA-2. Acta Neuropathol (Berl) 105: 271-280, 2003.
64. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21: 55-89, 2000.
65. Schulz RA, Yutzey KE. Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Dev Biol 266: 1-16, 2004.
66. Shuto T, Kukita T, Hirata M, Jimi E, Koga T. Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse bone marrow cultures. Endocrinology 134: 1121-1126, 1994.
67. Solomon AM, Bouloux PM. Modifying muscle mass - the endocrine perspective. J Endocrinol 191: 349-360, 2006.
68. St-Pierre SJ, Chakkalakal JV, Kolodziejczyk SM, Knudson JC, Jasmin BJ, Megeney LA. Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF-AT pathway. FASEB J 18: 1937-1939, 2004.
69. Sun L, Ma K, Wang H, Xiao F, Gao Y, Zhang W, Wang K, Gao X, Ip N, Wu Z. JAK1-STAT1-STAT3, a key pathway promoting proliferation and preventing premature differentiation of myoblasts. J Cell Biol 179: 129-138, 2007.
70. Suzuki N, Nakamura S, Mano H, Kozasa T. Galpha 12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF. Proc Natl Acad Sci USA 100: 733-738, 2003.
71. Thirion C, Stucka R, Mendel B, Gruhler A, Jaksch M, Nowak KJ, Binz N, Laing Lochmüller H NG. Characterization of human muscle type cofilin (CFL2) in normal and regenerating muscle. Eur J Biochem 268: 3473-3482, 2001.
72. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 99: 6567-6572, 2002.
73. Tidball JG, Wehling-Henricks M. Evolving therapeutic strategies for Duchenne muscular dystrophy: targeting downstream events. Pediatr Res 56: 831-841, 2004.
74. Toffolatti L, Rosa Gastaldo L, Patarnello T, Romualdi C, Merlanti R, Montesissa C, Poppi L, Castagnaro M, Bargelloni L. Expression analysis of androgen-responsive genes in the prostate of veal calves treated with anabolic hormones. Domest Anim Endocrinol 30: 38-55, 2006.
75. Tsai WJ, McCormick KM, Brazeau DA, Brazeau GA. Estrogen effects on skeletal muscle insulin-like growth factor 1 and myostatin in ovariectomized rats. Exp Biol Med 232: 1314-1325, 2007.
76. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
77. Uht RM, Anderson CM, Webb P, Kushner PJ. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. Endocrinology 138: 2900-2908, 1997.
78. Van Poucke C, Van Peteghem C. Development and validation of a multi-analyte method for the detection of anabolic steroids in bovine urine with liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 772: 211-217, 2002.
79. Vascellari M, Pozza G, Poppi L, Capello K, Angeletti R, Ravarotto L, Andrighetto I, Mutinelli F. Evaluation of indirect biomarkers for detecting corticosteroids used as illegal growth promoters in beef cattle. Vet Rec 163: 147-151, 2008.
80. Vianello S, Brazzoduro L, Dalla Valle L, Belvedere P, Colombo L. Myostatin expression during development and chronic stress in zebrafish (Danio rerio). J Endocrinol 176: 47-59, 2003.
81. Vuocolo T, Byrne K, White J, McWilliam S, Reverter A, Cockett NE, Tellam RL. Identification of a gene network contributing to hypertrophy in callipyge skeletal muscle. Physiol Genomics 28: 253-272, 2007.
82. Wang Y, Barbacioru C, Hyland F, Xiao W, Hunkapiller KL, Blake J, Chan F, Gonzalez C, Zhang L, Samaha RR. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. BMC Genomics 7: 59, 2006.
83. Wei L, Zhou W, Croissant JD, Johansen FE, Prywes R, Balasubramanyam A, Schwartz RJ. RhoA signaling via serum response factor plays an obligatory role in myogenic differentiation. J Biol Chem 273: 30287-30294, 1998.
84. Zhou F, Bouillard B, Pharaboz-Joly MO, Andre J. Non-classical antiestrogenic actions of dexamethasone in variant MCF-7 human breast cancer cells in culture. Mol Cell Endocrinol 66: 189-197, 1989.